BIO generates very strong cashflows considering their growth rate is so high. I assume they can acheive this becuase of their 59% plus margins. It appears that other than some minor debt, their sales growth is effectively self funding. Very impressive quarterly result with an even more ecouraging outlook.
BIO generates very strong cashflows considering their growth...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
59.0¢ |
Change
0.020(3.51%) |
Mkt cap ! $126.9M | |||
| Open | High | Low | Value | Volume |
| 57.5¢ | 64.0¢ | 56.5¢ | $942.7K | 1.552M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5295 | 58.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 59.0¢ | 13647 | 2 |
View Market Depth
| Last trade - 14.02pm 03/07/2024 (20 minute delay) ? |
| BIO (ASX) Chart |